GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » OPKO Health Inc (MEX:OPK) » Definitions » Cyclically Adjusted Revenue per Share

OPKO Health (MEX:OPK) Cyclically Adjusted Revenue per Share : MXN38.15 (As of Sep. 2024)


View and export this data going back to 2011. Start your Free Trial

What is OPKO Health Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

OPKO Health's adjusted revenue per share for the three months ended in Sep. 2024 was MXN3.424. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is MXN38.15 for the trailing ten years ended in Sep. 2024.

During the past 12 months, OPKO Health's average Cyclically Adjusted Revenue Growth Rate was 5.90% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 17.40% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 20.50% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 32.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of OPKO Health was 57.00% per year. The lowest was -3.90% per year. And the median was 24.90% per year.

As of today (2025-01-18), OPKO Health's current stock price is MXN29.46. OPKO Health's Cyclically Adjusted Revenue per Share for the quarter that ended in Sep. 2024 was MXN38.15. OPKO Health's Cyclically Adjusted PS Ratio of today is 0.77.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of OPKO Health was 118.53. The lowest was 0.48. And the median was 3.22.


OPKO Health Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for OPKO Health's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OPKO Health Cyclically Adjusted Revenue per Share Chart

OPKO Health Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18.69 23.29 32.43 36.67 31.20

OPKO Health Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 34.69 31.20 25.99 39.03 38.15

Competitive Comparison of OPKO Health's Cyclically Adjusted Revenue per Share

For the Diagnostics & Research subindustry, OPKO Health's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OPKO Health's Cyclically Adjusted PS Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, OPKO Health's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where OPKO Health's Cyclically Adjusted PS Ratio falls into.



OPKO Health Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, OPKO Health's adjusted Revenue per Share data for the three months ended in Sep. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=3.424/133.0289*133.0289
=3.424

Current CPI (Sep. 2024) = 133.0289.

OPKO Health Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201412 0.872 99.070 1.171
201503 1.027 99.621 1.371
201506 1.440 100.684 1.903
201509 4.689 100.392 6.213
201512 8.755 99.792 11.671
201603 9.179 100.470 12.154
201606 11.856 101.688 15.510
201609 10.435 101.861 13.628
201612 6.124 101.863 7.998
201703 8.982 102.862 11.616
201706 9.375 103.349 12.067
201709 7.982 104.136 10.197
201712 5.651 104.011 7.228
201803 8.278 105.290 10.459
201806 9.260 106.317 11.587
201809 8.347 106.507 10.426
201812 7.592 105.998 9.528
201903 7.359 107.251 9.128
201906 7.416 108.070 9.129
201909 7.703 108.329 9.459
201912 6.794 108.420 8.336
202003 7.741 108.902 9.456
202006 10.853 108.767 13.274
202009 14.759 109.815 17.879
202012 15.357 109.897 18.589
202103 17.389 111.754 20.699
202106 13.611 114.631 15.795
202109 12.170 115.734 13.989
202112 12.624 117.630 14.277
202203 9.927 121.301 10.887
202206 8.749 125.017 9.310
202209 4.818 125.227 5.118
202212 4.806 125.222 5.106
202303 5.698 127.348 5.952
202306 6.053 128.729 6.255
202309 4.139 129.860 4.240
202312 4.106 129.419 4.221
202403 4.078 131.776 4.117
202406 4.787 132.554 4.804
202409 3.424 133.029 3.424

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


OPKO Health  (MEX:OPK) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

OPKO Health's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=29.46/38.15
=0.77

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of OPKO Health was 118.53. The lowest was 0.48. And the median was 3.22.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


OPKO Health Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of OPKO Health's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


OPKO Health Business Description

Traded in Other Exchanges
Address
4400 Biscayne Boulevard, Miami, FL, USA, 33137
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a world supply-chain operation and holding company in Ireland. It also owns a specialty active pharmaceutical ingredients manufacturer in Israel. It operates in two segments Diagnostics and Pharmaceuticals.